The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, December 21, 2021
FDA has approved Xarelto (rivaroxaban) as tablets and an oral suspension to treat venous thromboembolism (VTE), or blood clots that form in the veins,...
read more
Tuesday, December 21, 2021
The U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and ...
read more
Tuesday, December 21, 2021
ANI Pharmaceuticals, Inc. announced that the Company received U.S. Food and Drug Administration (“FDA”) approval for the Abbreviated New Drug ...
read more
Tuesday, December 21, 2021
Pfizer Inc. and BioNTech SE announced an agreement has been reached with the European Commission (EC) and its member states to exercise an option to ...
read more
Tuesday, December 21, 2021
The Food and Drug Administration approved the second biosimilar insulin product, Eli Lilly’s Rezvoglar (insulin glargine-aglr). Rezvoglar (insulin ...
read more
Monday, December 20, 2021
Novartis announced the signing of an option, collaboration and license agreement with BeiGene, Ltd. for ociperlimab (BGB-A1217), expanding the company...
read more
Monday, December 20, 2021
Intra-Cellular Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) approved CAPLYTA for the treatment of depressive episodes ...
read more
Monday, December 20, 2021
AstraZeneca’s Saphnelo (anifrolumab) has been recommended for marketing authorization in the European Union (EU) as an add-on therapy for the ...
read more
Monday, December 20, 2021
Novartis announced top-line results from PEARL 1 and PEARL 2 Phase III studies in chronic spontaneous urticaria (CSU), which showed that the studies ...
read more
Monday, December 20, 2021
The U.S. Food and Drug Administration approved Vyvgart (efgartigimod) for the treatment of generalized myasthenia gravis (gMG) in adults who test ...
read more
Monday, December 20, 2021
AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients ...
read more
Monday, December 20, 2021
Sirona Biochem Corp. announced the advancement of 20 antiviral compounds to In Vitro testing. The compounds will be shipped to the Utah State ...
read more
Monday, December 20, 2021
Providence Therapeutics and Everest Medicines announced that their COVID-19 vaccine, PTX-COVID19-B, has been recommended by an independent advisory ...
read more
Friday, December 17, 2021
Medicago, a biopharmaceutical company headquartered in Quebec City, announced the submission of positive Phase 3 data for regulatory review by Health ...
read more
Friday, December 17, 2021
Merck and Ridgeback Biotherapeutics announced that the New England Journal of Medicine has published findings from the Phase 3 MOVe-OUT trial ...
read more